Tegeder I - Search Results

1

Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.

Lötsch J, Weyer-Menkhoff I, Tegeder I. Lötsch J, et al. Among authors: tegeder i. Eur J Pain. 2018 Mar;22(3):471-484. doi: 10.1002/ejp.1148. Epub 2017 Nov 21. Eur J Pain. 2018. PMID: 29160600 Review.

2

Release of glutamate, nitric oxide and prostaglandin E2 and metabolic activity in the spinal cord of rats following peripheral nociceptive stimulation.

Vetter G, Geisslinger G, Tegeder I. Vetter G, et al. Among authors: tegeder i. Pain. 2001 May;92(1-2):213-8. doi: 10.1016/s0304-3959(01)00258-5. Pain. 2001. PMID: 11323142

3

Drug interactions with patient-controlled analgesia.

Lotsch J, Skarke C, Tegeder I, Geisslinger G. Lotsch J, et al. Among authors: tegeder i. Clin Pharmacokinet. 2002;41(1):31-57. doi: 10.2165/00003088-200241010-00004. Clin Pharmacokinet. 2002. PMID: 11825096 Review.

4

Peripheral opioid analgesia in experimental human pain models.

Tegeder I, Meier S, Burian M, Schmidt H, Geisslinger G, Lötsch J. Tegeder I, et al. Brain. 2003 May;126(Pt 5):1092-102. doi: 10.1093/brain/awg115. Brain. 2003. PMID: 12690049 Clinical Trial.

5

The calpain inhibitor MDL 28170 prevents inflammation-induced neurofilament light chain breakdown in the spinal cord and reduces thermal hyperalgesia.

Kunz S, Niederberger E, Ehnert C, Coste O, Pfenninger A, Kruip J, Wendrich TM, Schmidtko A, Tegeder I, Geisslinger G. Kunz S, et al. Among authors: tegeder i. Pain. 2004 Jul;110(1-2):409-18. doi: 10.1016/j.pain.2004.04.031. Pain. 2004. PMID: 15275793

6

Essential role of the synaptic vesicle protein synapsin II in formalin-induced hyperalgesia and glutamate release in the spinal cord.

Schmidtko A, Del Turco D, Coste O, Ehnert C, Niederberger E, Ruth P, Deller T, Geisslinger G, Tegeder I. Schmidtko A, et al. Among authors: tegeder i. Pain. 2005 May;115(1-2):171-81. doi: 10.1016/j.pain.2005.02.027. Pain. 2005. PMID: 15836980

7

The partial 5-hydroxytryptamine1A receptor agonist buspirone does not antagonize morphine-induced respiratory depression in humans.

Oertel BG, Schneider A, Rohrbacher M, Schmidt H, Tegeder I, Geisslinger G, Lötsch J. Oertel BG, et al. Among authors: tegeder i. Clin Pharmacol Ther. 2007 Jan;81(1):59-68. doi: 10.1038/sj.clpt.6100018. Clin Pharmacol Ther. 2007. PMID: 17186000 Clinical Trial.

8

Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors.

Agarwal N, Pacher P, Tegeder I, Amaya F, Constantin CE, Brenner GJ, Rubino T, Michalski CW, Marsicano G, Monory K, Mackie K, Marian C, Batkai S, Parolaro D, Fischer MJ, Reeh P, Kunos G, Kress M, Lutz B, Woolf CJ, Kuner R. Agarwal N, et al. Among authors: tegeder i. Nat Neurosci. 2007 Jul;10(7):870-9. doi: 10.1038/nn1916. Epub 2007 Jun 10. Nat Neurosci. 2007. PMID: 17558404 Free PMC article.

9

Reduced hyperalgesia in homozygous carriers of a GTP cyclohydrolase 1 haplotype.

Tegeder I, Adolph J, Schmidt H, Woolf CJ, Geisslinger G, Lötsch J. Tegeder I, et al. Eur J Pain. 2008 Nov;12(8):1069-77. doi: 10.1016/j.ejpain.2008.02.004. Epub 2008 Apr 18. Eur J Pain. 2008. PMID: 18374612

10

Genetic deletion of synapsin II reduces neuropathic pain due to reduced glutamate but increased GABA in the spinal cord dorsal horn.

Schmidtko A, Luo C, Gao W, Geisslinger G, Kuner R, Tegeder I. Schmidtko A, et al. Among authors: tegeder i. Pain. 2008 Oct 31;139(3):632-643. doi: 10.1016/j.pain.2008.06.018. Epub 2008 Aug 12. Pain. 2008. PMID: 18701217

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results